45 employees
Spiden provides and develops products that enable real-time and continuous monitoring of blood biomarkers.
2017
$18M
from 3 investors over 3 rounds
Spiden raised $18M on April 29, 2021
Investors: Geberit, Ornament Health AG and b-to-v Partners AG